STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
SUTRO BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$11.26+0.32 (+2.88%)
Close on Oct 19, 2026
- Market cap
- $186.51M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Sutro Biopharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 8, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Current report | 8-K | May 14, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2026 | Apr 22, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 23, 2026 | Mar 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 10, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 17, 2025 | Dec 17, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 1, 2025 | Dec 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2025 | Jun 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 8, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 8, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2025 | Apr 14, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 13, 2024 | SEC EDGAR |
| Current report | 8-K | May 13, 2024 | May 13, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2024 | Apr 2, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2024 | Apr 2, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 25, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2024 | Mar 25, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2024 | Feb 9, 2024 | SEC EDGAR |